Potential savings from generic prescribing and generic substitution in South Africa

Autor: KARIM, SS ABDOOL, PILLAI, G, ZIQUBU-PAGE, TT, CASSIMJEE, MH, MORAR, MS

Publikováno v: Health Policy and Planning, 1996 Jun 01. 11(2), 198-202.

Externí odkaz: https://www.jstor.org/stable/45089367

Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel.

Autor: Archary D; Centre for the AIDS Program of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Seaton KE; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Passmore JS; Centre for the AIDS Program of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Werner L; Centre for the AIDS Program of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Deal A; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Dunphy LJ; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Arnold KB; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Yates NL; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA., Lauffenburger DA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Bergin P; Imperial College, International AIDS Vaccine Initiative Core Immune Monitoring Laboratory, London, UK., Liebenberg LJ; Centre for the AIDS Program of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Samsunder N; Centre for the AIDS Program of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Mureithi MW; KAVI Institute of Clinical Research, School of Medicine, College of Health Sciences, University of Nairobi, Nairobi, Kenya., Altfeld M; Heinrich-Pette Institut, Leibniz Institute for Experimental Virology, University of Hamburg, Hamburg, Germany., Garrett N; Centre for the AIDS Program of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Karim QA; Centre for the AIDS Program of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA., Karim SA; Centre for the AIDS Program of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA., Morris L; Centre for the AIDS Program of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Tomaras GD; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.; Departments of Surgery, Immunology and Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA.

Publikováno v: Mucosal immunology [Mucosal Immunol] 2016 May; Vol. 9 (3), pp. 821-833. Date of Electronic Publication: 2016 Jan 27.